Baxter drops own products to play middleman to Gambro's haemodialysis line
This article was originally published in Clinica
Baxter is to discontinue its line of haemodialysis (HD) devices and instead take on board the HD product portfolio of fellow renal care company Gambro.
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.